PACRG-AS1
gene geneOn this page
Summary
PACRG-AS1 (PACRG antisense RNA 1, HGNC:27772) is a long non-coding RNA gene on chromosome 6q26.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27772 |
| Approved symbol | PACRG-AS1 |
| Name | PACRG antisense RNA 1 |
| Location | 6q26 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000281692 |
| Ensembl biotype | lncRNA |
| Entrez | 285796 |
| RNAcentral | URS000075DA03 — lncRNA, 2135 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 lncRNA
ENST00000626335, ENST00000655608, ENST00000663455, ENST00000667079, ENST00000670113
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000626335 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003762429 | 163310033 | 163310970 |
| ENSE00003771552 | 163320401 | 163320559 |
| ENSE00003772886 | 163323391 | 163324069 |
| ENSE00003881167 | 163324370 | 163324446 |
Expression profiles
Bgee: expression breadth broad, 97 present calls, max score 69.98.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2251 / max 30.1626, expressed in 63 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 76585 | 0.2095 | 62 |
| 76586 | 0.0156 | 9 |
Top tissues by expression
199 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 69.98 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 64.01 | gold quality |
| right uterine tube | UBERON:0001302 | 62.26 | gold quality |
| spinal cord | UBERON:0002240 | 61.85 | gold quality |
| cortical plate | UBERON:0005343 | 61.16 | silver quality |
| prefrontal cortex | UBERON:0000451 | 59.88 | gold quality |
| corpus callosum | UBERON:0002336 | 59.39 | gold quality |
| amygdala | UBERON:0001876 | 58.48 | gold quality |
| putamen | UBERON:0001874 | 58.30 | gold quality |
| substantia nigra | UBERON:0002038 | 56.83 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 56.42 | gold quality |
| caudate nucleus | UBERON:0001873 | 55.69 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 55.66 | gold quality |
| Ammon’s horn | UBERON:0001954 | 54.81 | gold quality |
| midbrain | UBERON:0001891 | 54.80 | gold quality |
| hypothalamus | UBERON:0001898 | 53.97 | gold quality |
| sural nerve | UBERON:0015488 | 53.64 | silver quality |
| frontal cortex | UBERON:0001870 | 53.46 | gold quality |
| neocortex | UBERON:0001950 | 52.33 | gold quality |
| nucleus accumbens | UBERON:0001882 | 52.11 | gold quality |
| right frontal lobe | UBERON:0002810 | 51.79 | gold quality |
| forebrain | UBERON:0001890 | 51.59 | gold quality |
| brain | UBERON:0000955 | 51.26 | gold quality |
| cerebral cortex | UBERON:0000956 | 51.19 | gold quality |
| tibial nerve | UBERON:0001323 | 51.15 | gold quality |
| temporal lobe | UBERON:0001871 | 50.73 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 50.48 | gold quality |
| heart left ventricle | UBERON:0002084 | 49.82 | gold quality |
| cardiac ventricle | UBERON:0002082 | 49.43 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 49.34 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.96 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.